Astute Medical, Inc. is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel in vitro diagnostic tests. read more...
SAN DIEGO - June 7, 2012 - Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced the completion of a $40.4 million Series C financing led by MPM Capital and including new investor read more...
Please direct all inquiries to the address listed below:
Astute Medical, Inc.
3550 General Atomics Court
San Diego, California 92121